SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

DSGN

Design Therapeutics, Inc.
NASDAQHealth Care

Latest close: 10.31 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 3, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  2. Aug 3, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Jun 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record24213 flagged findings
Reported transactions (Form 4)54since Mar 30, 2021 · and 4 other holdings
Corporate events (8-K)8since Jun 7, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-04-28share offering or dilution eventrecentOpen filing ↗
    “…March 31, 2026 as compared to the same period in 2025. Liquidity and Capital Resources We have incurred net losses and negative…”
    +1 more passage from the same document
    • “…and Capital Resources We have incurred net losses and negative cash flows from operations since our inception and anticipate…”
  • 2026-03-09share offering or dilution eventrecentOpen filing ↗
    “…quality and manufacturing capabilities, incur significant commercialization expenses for marketing, sales, manufacturing and…”
    +1 more passage from the same document
    • “…expenses for marketing, sales, manufacturing and distribution, if we obtain marketing approval for any of our product…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 242)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Point72 Asset Management, L.P. · 3.8% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · Sirenia Capital Management LP · 9.5% · event on Jun 30, 26
  • Aug 3, 2610-Q ↗Quarterly report
  • Aug 3, 268-K ↗Current report · Results
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • Jun 11, 268-K ↗Current report · Shareholder vote results
  • Jun 9, 26SCHEDULE 13G ↗Passive stake · Point72 Asset Management, L.P. · 5.1% · event on Jun 8, 26
  • May 18, 268-K ↗Current report · Other events
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Point72 Asset Management, L.P. · 4.4% · event on Mar 31, 26 · amendment
  • Apr 28, 2610-Q ↗Quarterly report
  • Apr 28, 268-K ↗Current report · Results · Communication to the market
  • Apr 23, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 23, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 1, 26Form 4 ↗Insider transaction
  • Apr 1, 26Form 3 ↗Insider transaction
  • Apr 1, 268-K ↗Current report · A senior executive left or was appointed
  • Mar 11, 26SCHEDULE 13D/A ↗Stake with intent to influence · Simeon George · 10.7% · event on Mar 9, 26 · amendment
  • Mar 9, 2610-K ↗Annual report
  • Mar 9, 268-K ↗Current report · Results
  • Feb 17, 26SCHEDULE 13G/A ↗Passive stake · Point72 Asset Management, L.P. · 9.4% · event on Dec 31, 25 · amendment

242 filings on record, the oldest from Feb 23, 21.

Listing the 25 most recent filings of the 242 on record.

8-Ks, explained

Structure1Governance7
  • Governance4 senior executive changes2023 – 2026show all 4hide
    • Apr 1, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jan 30, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Sep 10, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Aug 25, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 22, 22StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Governance3 senior executive changes2021show all 3hide
    • Aug 20, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Aug 6, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 7, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Simeon George10.7%Mar 9, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Logos Global Management LP4.4%Nov 14, 25SCHEDULE 13D/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Sirenia Capital Management LP9.5%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Star Irrevocable Trust #1 dated April 22, 20196.9%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Light Irrevocable Trust #1 dated April 22, 20196.9%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Point72 Asset Management, L.P.3.8%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 13, 25Sell$1.8MArsani William↗
  • Aug 13, 25Sell$1.1MArsani William↗
  • Dec 18, 24Sell$24KDeepa Prasad↗
  • Aug 9, 24Sell$3.5MArsani William↗
  • Mar 25, 24Buy$5KHeather A. Berger↗
  • Mar 25, 24Buy$67KJohn P. Schmid↗
  • Mar 22, 24Buy$33KJohn P. Schmid↗
  • Sep 29, 23Buy$49KRODNEY W LAPPE↗
  • Aug 29, 23Buy$4.8MArsani William↗
  • Aug 29, 23Buy$28KDeepa Prasad↗
  • Aug 28, 23Buy$591KArsani William↗
  • Mar 30, 21Buy$14.0MArsani William↗
Stock compensation, tax and giftsshow the 2 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Mar 30, 21Otheramount n/aArsani William↗
  • Mar 30, 21Otheramount n/aArsani William↗

The full record holds 14 transactions and goes back to Mar 30, 21.

Its sector and its market

Design Therapeutics, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Design Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Design Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
242 documents on file, from Feb 23, 2021 to Aug 14, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Design Therapeutics, Inc. (DSGN): stock price history, insider trades and SEC filings — HornScout